Weimai Qingtong Medical Technology (Wuxi) Co., Ltd. announced that it has received nears CNY 100 million in a round of funding on March 13, 2024. The transaction involved participation from new investor CDH Investment Management Company Limited, Changzhou Lizhong Investment Management Co., Ltd., Yunnan Botanee Bio-Technology Group Co.LTD, Guangdong Evergreen Conglomerate Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
55.35 CNY | -3.76% | 0.00% | -18.81% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.81% | 3.21B | |
-3.33% | 249B | |
+10.09% | 18.86B | |
0.00% | 17.37B | |
-1.32% | 10.65B | |
-7.73% | 10.26B | |
+3.86% | 6.72B | |
+9.76% | 5.94B | |
-0.06% | 4.55B | |
-16.98% | 3.83B |
- Stock Market
- Equities
- 300957 Stock
- News Yunnan Botanee Bio-Technology Group Co.LTD
- Weimai Qingtong Medical Technology Co., Ltd. announced that it has received funding from CDH Investment Management Company Limited, Changzhou Lizhong Investment Management Co., Ltd., Yunnan Botanee Bio-Technology Group Co.LTD, Guangdong Evergreen Conglomerate Co., Ltd.